CLOs on the Move

Censys

www.censys.io

 
Censys allows users to discover the devices, networks, and infrastructure on the Internet and monitor how it changes over time. Censys was created in 2015 at the University of Michigan by the security researchers who developed ZMap, the most widely used tool for Internet-wide scanning. Over the past five years, the team has performed thousands of Internet-wide scans, consisting of trillions of probes, and has played a central role in the discovery or analysis of some of the most significant Internet-scale vulnerabilities: FREAK, Logjam, DROWN, Heartbleed, and the Mirai botnet. Today, Censys has become the gold standard in data-driven security, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.censys.io
  • 116 S Main Street Upper Suite
    Ann Arbor, MI USA 48104
  • Phone: 248.629.0125

Executives

Name Title Contact Details

Similar Companies

The Presentation Company

Up-level your teams communication skills. Learn more about The Presentation Companys corporate storytelling and data visualization virtual workshops.

Resolve Systems

Resolve helps enterprise IT teams achieve agileoperations with an industry-leading intelligent automation platform that powers more than a million automations every day – from simple, repetitive tasks to insanely complex processes that go well beyond what you imagine is automatable. Purpose-built to address challenges posed by increasing IT complexity, Resolve`s no-code IT automation enables organizations to maximize operational efficiency, reduce costs, quickly troubleshoot and fix problems, improve service levels, accelerate service delivery, and deliver rapid time to value.

Fullstack Academy

Fullstack Academy is a top-ranked coding bootcamp with campuses in NYC, Chicago, and online. Want to become a professional software developer? Check us out!

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.

Hello Alfred

Named one of the 50 Most Innovative Companies in the World by Fast Company in 2018, Hello Alfred is quickly establishing itself as one of the most disruptive commerce channels around, trusted to deliver services, goods and retail experiences past your door.